Predicted to enable serine-type endopeptidase inhibitor activity. Predicted to act upstream of or within negative regulation of peptidase activity. Predicted to be located in extracellular space. Is expressed in several structures, including central nervous system; smooth muscle tissue; spleen; stomach; and uterus. [provided by Alliance of Genome Resources, Apr 2022]